These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 29643520

  • 1. [Comparison of gut microbiotal compositional analysis of patients with irritable bowel syndrome through different bioinformatics pipelines].
    Zhu SW, Liu ZJ, Li M, Zhu HQ, Duan LP.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr 18; 50(2):231-238. PubMed ID: 29643520
    [Abstract] [Full Text] [Related]

  • 2. A comparison of sequencing platforms and bioinformatics pipelines for compositional analysis of the gut microbiome.
    Allali I, Arnold JW, Roach J, Cadenas MB, Butz N, Hassan HM, Koci M, Ballou A, Mendoza M, Ali R, Azcarate-Peril MA.
    BMC Microbiol; 2017 Sep 13; 17(1):194. PubMed ID: 28903732
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y.
    Neurogastroenterol Motil; 2012 Jun 13; 24(6):521-30, e248. PubMed ID: 22339879
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ, Wei H, Duan LP, Zhu SW, Zhang L, Wang K.
    Zhonghua Yi Xue Za Zhi; 2016 Jun 28; 96(24):1896-902. PubMed ID: 27373356
    [Abstract] [Full Text] [Related]

  • 17. Baseline gut microbial profiles are associated with the efficacy of Bacillus subtilis and Enterococcus faecium in IBS-D.
    Hong G, Li Y, Yang M, Li G, Jin Y, Xiong H, Qian W, Hou X.
    Scand J Gastroenterol; 2023 Apr 28; 58(4):339-348. PubMed ID: 36281578
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W, Wang HF, Zhang Y, Zhang YL, Niu BY, Yao SK.
    World J Gastroenterol; 2020 Dec 07; 26(45):7153-7172. PubMed ID: 33362374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.